Lifecare ASA (STO:LIFEO)

Market Cap	88.60M -9.6%
Revenue (ttm)	7.25M -19.9%
Net Income	-132.99M
EPS	-0.45
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	600
Open	0.3315
Previous Close	0.4000
Day's Range	0.3315 - 0.3315
52-Week Range	0.2875 - 18.1000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 19, 2026

About Lifecare ASA

Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a 3D printed nano-sensor for monitoring glucose levels in patients with diabetes and for veterinary applications; as well as medical devices that remove subdermal implants. Lifecare ASA was founded in 2006 and is headquartered in Bergen, Norway.

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2006
• Employees: 25
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: LIFEO

Financial Performance

In 2025, Lifecare ASA's revenue was 6.64 million, a decrease of -31.34% compared to the previous year's 9.67 million. Losses were -119.51 million, 66.6% more than in 2024.

Financial numbers in NOK

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 25, 2026

Data Sources Report a data error